Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank53
3Y CAGR-22.0%
5Y CAGR-8.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-22.0%/yr
Quarterly compound
5Y CAGR
-8.4%/yr
Recent deceleration
Percentile
P53
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 5.02% |
| Q2 2025 | 38.94% |
| Q1 2025 | -65.33% |
| Q4 2024 | -29.09% |
| Q3 2024 | 0.48% |
| Q2 2024 | 7.77% |
| Q1 2024 | 24.49% |
| Q4 2023 | 9.67% |
| Q3 2023 | 6.55% |
| Q2 2023 | -6.03% |
| Q1 2023 | -12.67% |
| Q4 2022 | 8.46% |
| Q3 2022 | 10.57% |
| Q2 2022 | -19.64% |
| Q1 2022 | 17.36% |
| Q4 2021 | -19.09% |
| Q3 2021 | -2104.63% |
| Q2 2021 | 105.65% |
| Q1 2021 | -43.73% |
| Q4 2020 | 27.50% |
| Q3 2020 | 7.78% |
| Q2 2020 | 21.80% |
| Q1 2020 | 11.30% |
| Q4 2019 | -37.65% |
| Q3 2019 | 4.25% |
| Q2 2019 | -31.14% |
| Q1 2019 | -8.14% |
| Q4 2018 | -74.71% |
| Q3 2018 | -57.37% |
| Q2 2018 | 13.61% |
| Q1 2018 | 0.00% |